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ABSTRACT Nitric oxide (NO) is an intercellular messen-
ger involved with various aspects of mammalian physiology
ranging from vasodilation and macrophage cytotoxicity to
neuronal transmission. NO is synthesized from L-arginine by
NO synthase (NOS). Here, we report the cloning of a Dro-
sophila NOS gene, dNOS, located at cytological position 32B.
The dNOS cDNA encodes a protein of 152 kDa, with 43%
amino acid sequence identity to rat neuronal NOS. Like
mammalian NOSs, DNOS protein contains putative binding
sites for calmodulin, FMN, FAD, and NADPH. DNOS activity
is Ca2+/calmodulin dependent when expressed in cell culture.
An alternative RNA splicing pattern also exists for dNOS,
which is identical to that for vertebrate neuronal NOS. These
structural and functional observations demonstrate remark-
able conservation of NOS between vertebrates and inverte-
brates.
Nitric oxide (NO) is synthesized by NO synthases (NOSs)
during conversion of L-arginine to L-citrulline (for reviews, see
refs. 1 and 2). Biochemical characterization of NOSs has
distinguished two general classes: (i) constitutive, dependent
on exogenous Ca2+/calmodulin, and (ii) inducible, indepen-
dent of exogenous Ca2+/calmodulin. Analyses ofcDNA clones
have identified three distinct NOS genes in mammals (3-6):
neuronal, endothelial, and macrophage. The neuronal and
endothelial NOSs are constitutive, and the macrophage NOS
is inducible. The nomenclature for these different isoforms
used here is historical, as it is clear now that one or more
isoforms can be present in the same tissue (7).
As a diffusible, free-radical gas, NO is a multifunctional
messenger affecting many diverse aspects of mammalian phys-
iology (for review, see ref. 8), such as regulation of vascular
tone, macrophage-mediated cytotoxicity, and cell-cell inter-
actions in the nervous system, including synaptogenesis and
apoptosis during development of the rat central nervous
system (9) and during neuronal cell differentiation (10). NO
also appears to be involved with long-term potentiation in
hippocampus and with long-term depression in cerebellum,
two forms of synaptic plasticity that may underlie behavioral
plasticity (11-15). Consistent with these cellular studies, inhi-
bition of NOS activity may disrupt learning (refs. 16-19, but
see refs. 20 and 21).
Many of the above results are based on pharmacological
studies using inhibitors of NOS or donors of NO. Interpreta-
tions of such studies usually are limited because the drugs
interact with more than one target and cannot be delivered to
specific sites. A molecular genetic approach can overcome
these problems, however, by disrupting a specific gene, the
product of which may be one of the drug's targets. Recently,
such an approach has been attempted in mice via generation
of a knockout mutation of the neuronal NOS (nNOS) (22).
While nNOS mutants appeared fully viable and fertile, minor
defects in stomach morphology and hippocampal long-term
potentiation were detected (22, 23). Taken together, the above
reports suggest roles for NO in developmental and behavioral
plasticity of the vertebrate central nervous system.
In this paper, we report the molecular characterization of a
Drosophila NOS gene, dNOS.t The primary structure and
activity of DNOS protein is strikingly similar to the class of
constitutively expressed mammalian NOSs, the activities of
which are regulated by transient changes in intracellular Ca2+
concentration. We also have detected a splicing variant of the
dNOS transcript which is identical to that described for the
nNOS. This evolutionary conservation of structure and func-
tion between Drosophila and vertebrate NOSs suggests a
universality of NOS function underlying neuronal plasticity.
MATERIALS AND METHODS
Library Screens. We have screened 6 x 104 plaques of a
Drosophila ADASH genomic library with the 1.3-kb Bgl II
fragment of rat nNOS cDNA (nt 3282-4573) under low-
stringency conditions of 40% formamide as described (24).
Fifty positive phage plaques were purified and grouped on the
basis of inter se hybridization results. The contig containing
the 2.4R fragment of dNOS comprised 15 phage clones.
Regions of cross-hybridization to the rat probe were identified
and subcloned, and three of them were sequenced. The other
two did not contain sequences similar to any protein in the data
base. Approximately 5 x 105 plaques of Drosophila head
cDNA library (a gift from P. Salvaterra; Beckman Research
Institute, City of Hope, Duarte, CA) were screened with the
2.4R fragment isolated from phage clone A8.11 by using
standard conditions. Eight positive phage plaques were iden-
tified. All phage purification and cloning steps were done by
following standard methods (25). cDNA fragments were in-
serted into Bluescript (Stratagene) and sequenced on both
strands with Sequenase 2.0 (United States Biochemical).
Cell Culture Assay of DNOS Activity. The expression con-
struct for activity assays contained dNOS cDNA (with an Xba
I restriction site engineered immediately upstream of the ATG
initiation codon) inserted into the Xba I and Sma I restriction
sites of the pCGN vector (26). Human 293 embryonic kidney
cells were transfected with 15 ,ug of either the dNOS construct
or vector DNA precipitated with calcium phosphate as de-
scribed (27). Cells were collected 2 days later, and protein
extracts were prepared as described (25). The enzymatic assay
for NOS activity was done essentially as described (28). A 100-
,ul reaction mixture containing 25 .ul (50-100 jig) of soluble
protein extract, 50 mM Hepes (pH 7.4), 1 mM dithiothreitol,
0.8 mM CaCl2, 1 mM NADPH, 10 ,ug of calmodulin per ml, 2
Abbreviations: NO, nitric oxide; NOS, NO synthase; nNOS, neuronal
NOS; RT-PCR, reverse transcription-PCR; ORF, open reading
frame.
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FIG. 1. Comparison of the deduced amino acid sequences of DNOS and mammalian NOSs. Numbering starts at the first methionine in each
ORF. Putative cofactor-binding sites for heme, calmodulin (CaM), FMN, FAD pyrophosphate (FAD.PPi), FAD isoalloxazine (FAD-Iso), NADPH
ribose (NADPH.Ribose), NADPH adenine (NADPH.Ade), and the C-terminal conserved sequence necessary for NADPH binding (33) are
overlined. Amino acids that have been proposed as contacts with FAD and NADPH on the basis of the crystal structure of ferrodoxin-NADP+
reductase (34) are conserved at equivalent positions (-). DNOS, Drosophila NOS; RNNOS, rat nNOS (3); BENOS, bovine endothelial NOS (5);
and MMNOS, mouse macrophage NOS (6). Sequence alignment performed by GENEWORKS 2.3 (IntelliGenetics).
Al of L-[3H]arginine (35.7 Ci/mmol; 1 Ci = 37 GBq; NEN),
and 50 mM L-valine was incubated for 60 min at 37°C. The
reaction was stopped and processed as described (28).
Detection of DNOS Protein in Cell Extracts. Anti-DNOS
antibodies were raised against a glutathione S-transferase
fusion protein containing the 97 N-terminal amino acids of the
dNOS open reading frame (ORF) (0.29-kb Eamn1051-Sac I
fragment of dNOS cDNA) expressed from pGEX-KG (29) in
Escherichia coli strain BL21 (DE3) and purified over a gluta-
thione-Sepharose column (Pharmacia) as described (30). Im-
munization of rabbits and serum preparation were done by
Hazleton Research Products (Denver). SDS/7.5% PAGE (25
,ug of protein per lane) and Western blots were done by
following standard methods (25). The DNOS protein was
detected by using a 1:500 dilution of rabbit serum and anti-
rabbit alkaline phosphatase conjugate (Promega).
RNA Analysis. Heads and bodies of adult flies were sepa-
rated on sieves. Total RNA was isolated as described (31).
Poly(A)+ RNA selection and Northern blot analysis [10 ,Ag of
poly(A)+ RNA per lane] were done by following standard
methods (25). The blot was hybridized with random-primed
dNOS cDNA (106 cpm/ml), washed in 0.1x SSC (lx SSC =
0.15 M NaCl/0.015 M sodium citrate)/0.1% SDS at 65°C and
exposed to x-ray film for 72 h. Each reverse transcription-PCR
(RT-PCR) reaction was started with 30 ng of poly(A)+ head
RNA, 90 ng of the bottom primer (nt 1793-1817 of dNOS
cDNA) and 5 units of rTth DNA polymerase (Perkin-Elmer)
in the MJ Research Minicycler as follows: 95°C for 1 min, 670C
for 45 sec, and 70°C for 13 min. The second stage, with 90 ng
of the top primer (nt 1374-1399), was carried out for 35 cycles
as follows: 949C for 45 sec, 63°C for 45 sec, and 70°C for 90 sec.
Products of the reaction were resolved on a denaturing 8%
polyacrylamide gel, cloned, and sequenced.
RESULTS
Identification of dNOS cDNA. To identify candidate Dro-
sophila NOS homologs, a fragment of the rat nNOS cDNA (3)
was hybridized at low stringency to a phage library of the
Drosophila genome. The rat cDNA fragment encoded the
binding domains of FAD and NADPH (amino acids 979-
1408), which are cofactors required for NOS activity and,
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therefore, were expected to be conserved in fruit fly homologs.
Several Drosophila genomic clones were identified by the rat
probe and were classified into eight contigs. Sequence analysis
of three restriction fragments from these genomic clones
revealed one (2.4R) with high sequence similarity to mamma-
lian NOSs. The deduced amino acid sequence of the ORF
encoded within the 2.4R fragment indicated 40% sequence
identity to the rat nNOS and binding sites for FAD and
NADPH.
The 2.4R DNA fragment then was used to probe a Dro-
sophila adult head cDNA library, and eight clones were
isolated. Restriction analysis indicated that all contained iden-
tical inserts and, thus, defined a predominant transcript ex-
pressed by this Drosophila gene. One clone (c5.3) was se-
quenced in both directions. The 4491-bp cDNA contained one
long ORF of 4050 bp. The methionine codon initiating this
ORF was preceded by ACAAG, which is a good match to the
translation start consensus sequence (A/CAAA/C) for Dro-
sophila genes (32). Conceptual translation of this ORF yielded
a protein of 1350 amino acids with a molecular weight of
151,842.
Primary Structure of ONOS Protein. Comparison of the
amino acid sequence of this deduced Drosophila protein
(DNOS) with sequences of mammalian NOSs revealed that
DNOS is 43% identical to nNOS, 40% identical to endothelial
NOS, and 39% identical to macrophage NOS. It also revealed
similar structural motifs in DNOS (Fig. 1A). The C-terminal
half of the DNOS protein contains regions of high similarity
corresponding to the presumptive FMN-, FAD-, and NADPH-
binding sites. Amino acids thought to be important for making
contacts with FAD and NADPH in mammalian NOSs (6) are
conserved in DNOS. The middle section of DNOS, between
residues 215 and 746, showed the highest similarity to mam-
malian NOSs: it is 61% identical to the neuronal isoform and
53% identical to endothelial and macrophage isoforms. This
region contains the presumptive heme- and calmodulin-
binding sites in mammalian NOS enzymes. The heme-binding
site was proposed to be centered around C-415 in the nNOS
(35, 36), and this cysteine residue has been shown to be
important for heme binding (37). The sequence surrounding
the corresponding cysteine (C-329) in DNOS is well con-
served. The region located between residues 643 and 671 has
the characteristics of a calmodulin-binding domain (basic,
amphiphilic a-helix) (38). The amino acid sequence between
these two sites is very well conserved among all four NOS
proteins, suggesting the location of functionally important
domains, such as binding sites for arginine and tetrahydro-
biopterine or a dimerization domain (39, 40). DNOS also has
a protein kinase A consensus site (41) (at S-287) in a position
similar to that in neuronal and endothelial NOSs (3, 4).
The 214-amino acid N-terminal region of DNOS shows no
obvious similarity to its equivalent portion of nNOS or to the
much shorter N-terminal domains of endothelial and macro-
phage NOSs. This region of DNOS contains an almost unin-
terrupted homopolymeric stretch of 24 glutamine residues.
Such glutamine-rich domains, found in many Drosophila and
vertebrate proteins, have been implicated in protein-protein
interactions that regulate the activation of transcription (42,
43). Thus, this domain of DNOS might be involved with
protein-protein interactions necessary for localization and/or
regulation of DNOS activity.
The above sequence comparisons suggest that we have
identified a Drosophila structural homolog of a vertebrate NOS
gene. The order of the putative functional domains in the
DNOS protein is identical to that of mammalian enzymes.
Structural predictions based on several protein algorithms
(Kyte-Doolittle and Gamier algorithms via GENEWORKS 2.3
software; IntelliGenetics) also indicate that general aspects of
DNOS protein secondary structure (hydrophobicity plot, dis-
tribution of a-helixes and (3-strands) from the putative heme-
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binding domain to the C terminus are similar to those of
mammalian NOSs (data not shown). DNOS does not contain
the internal deletion present in the macrophage NOS (6)
(corresponding to residues 742-809 in DNOS), which suggests
that it is more closely related to neuronal and endothelial
NOSs. Similarly to the nNOS, DNOS has the N-terminal
domain larger than that of other NOS proteins. Unlike the
endothelial NOS (4, 5), DNOS does not have an N-terminal
myristoylation site. Like all described mammalian NOSs,
DNOS does not contain a transmembrane domain (as defined
by Kyte-Doolittle).
DNOS Expressed in Cell Culture Has NOS Activity. To
establish that our putative DNOS protein functions as a NOS,
the dNOS cDNA was expressed transiently in human 293
embryonic kidney cells, which have been used routinely in
studies of mammalian NOSs (3, 44). Protein extracts prepared
from dNOS-transfected cells contained a 150-kDa polypep-
tide, which was recognized by a polyclonal antibody raised
against the N-terminal domain of DNOS (Fig. 2A4, lane 293 +
dNOS). This immunoreactive polypeptide was the size ex-
pected for DNOS and was absent from cells transfected with
the pCGN vector alone (lane 293 + vector).
Extracts made from dNOS-transfected human 293 embry-
onic kidney cells showed significant NOS activity, as measured
by the conversion of L-arginine to L-citrulline (28) (0.1276 +
0.002 pmol mg-1 min-1; Fig. 2B, group B). This level of NOS
activity was 20-fold higher than that of an extract of cells
transfected with the pCGN vector alone (0.0062 ± 0.002
pmol mg-1 min-1; Fig. 2B, group A). (In a parallel experiment,
the specific activity of rat nNOS expressed from the same
vector in human 293 embryonic kidney cells was 3.0 ± 0.02
pmol mg-1-min-1; n = 4.) DNOS activity was dependent on

































FIG. 2. Expression of DNOS enzymatic activity in human 293
embryonic kidney cells. (A) Western blot analysis of protein extracts
from cells transfected with vector alone (lane 293 + vector) or with
dNOS cDNA construct (lane 293 + dNOS). A total of 25 ,ug of soluble
protein extract was resolved by electrophoresis through a 7.5% poly-
acrylamide gel, transferred to nitrocellulose membrane, and treated
with anti-DNOS antibody. The arrow indicates the position of the
DNOS protein. Positions of molecular mass markers (in kDa) are
shown on the left. (B) DNOS enzyme activity measured by conversion
of L-[3H]arginine to L-[3H]citrulline. Enzymatic activity was detected
in cells transfected with the dNOS cDNA construct (groups B-D) but
not in cells transfected with pCGN vector alone. It is presented as
specific activity (pmol of citrulline per mg-min-'). DNOS activity also
was measured in the presence of 1 mM EGTAwithout exogenous Ca2+
or calmodulin (CaM) (group C), or in the presence of 100 ,uiM
Nw-nitro-L-arginine methyl ester (L-NAME) (group D). n = 4 reac-
tions per group.
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necessary for activity of constitutive mammalian NOSs (28,
45). DNOS activity was reduced 90% by the Ca2+ chelator
EGTA (Fig. 2B, group C). Also, 500 AM N-(6-aminohexyl)-1-
naphthalenesulfonamide (W5), a calmodulin antagonist which
inhibits activity of nNOS (28), diminished DNOS activity 82%
(0.0222 ± 0.001 pmolmg-1 min-1; n = 2) (data not shown). In
the absence of exogenous NADPH, DNOS (or nNOS) activity
was reduced 20% (0.1061 ± 0.011 pmol mg-1 min-1; n = 4 for
DNOS; 2.7935 ± 0.033 pmol-mg-1min-1; n = 2 for nNOS).
DNOS activity also was blocked by inhibitors of mammalian
NOSs (46). N"'-nitro-L-arginine methyl ester (L-NAME) reduced
DNOS activity 84% (Fig. 2B, group D), and 100 AuM NO-
monomethyl-L-arginine acetate produced a complete block
(0.0001 ± 0.0002 pmol-mg-1min-1; n = 2) (data not shown).
These enzymatic data demonstrate that DNOS is a Ca2+/cal-
modulin-dependent NOS.
An Alternative Splicing Pattern of NOS Transcripts Is
Conserved Between Vertebrates and Flies. Northern blot
analysis indicated a 5.0-kb dNOS transcript that was expressed
(preferentially) in adult fly heads but not bodies (Fig. 3A).
More sensitive RT-PCR experiments, however, detected a
similar dNOS message in poly(A)+ RNA from fly bodies (data
not shown). nNOS genes from mice and humans, however,
have been shown recently to produce two alternatively spliced
transcripts, the shorter of which yields a protein containing a
105-amino acid in-frame deletion (residues 504-608 in mouse
or rat nNOS) (48). RT-PCR amplification of Drosophila -head
mRNA revealed two DNA fragments: a 444-bp fragment
corresponding to the vertebrate long form and the 129-bp
fragment corresponding to the vertebrate short form (Fig. 3B).
Conceptual translation of the 129-bp sequence indicated a
splicing pattern identical to that for the mammalian nNOS
gene (Fig. 3C), thereby confirming the existence of a short





















Our discovery of a NOS homolog in Drosophila provides
definitive proof that invertebrates produce NO and, as sug-
gested by recent reports (see below), most likely use it for
intercellular signaling. Our data also suggest that a NOS gene
was present in an ancestor common to vertebrates and arthro-
pods, implying that NOS has existed for at least 600 million
years. Thus, we expect NOS genes to be prevalent throughout
the animal kingdom.
Consistent with this view are existing histochemical data.
NOS activity has been detected in several invertebrate tissue
extracts, including Drosophila brain (49-53). Applications of
NOS inhibitors or NO-generating substances have been shown
to modulate the activity of buccal motoneurones in Lymnaea
stagnalis (52) and the oscillatory dynamics of olfactory neurons
in procerebral lobe of Limax maximus (54). NADPH-
diaphorase staining, a relatively specific indicator of NOS
protein in fixed vertebrate tissue samples (55, 56), also has
suggested the presence of NOS in Drosophila brain (53). Our
molecular cloning of dNOS considerably strengthens the no-
tion that this NADPH-diaphorase staining reflects, at least in
part, the presence of NOS.
Intriguingly, the presence of identical alternative transcripts
for dNOS and nNOS genes suggests a conserved function.
Presently, this putative in vivo function is unknown. A recom-
binant mouse molecule, which corresponds, in part, to the
shorter splice form, does not show NOS activity in cell culture
(57). Since NOS molecules must dimerize to function (40, 58),
we speculate that the shorter splice form may block activity of
the long form in a "dominant-negative" fashion through
dimerization. Alternatively, since this molecule retains the
NADPH-diaphorase activity (57), its function might be to
create other products, like superoxide (59). Generation of
transgenic flies carrying an inducible dNOS short-form may
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494 618
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FIG. 3. dNOS transcripts in adult Drosophila. (A) Northern blot analysis ofdNOS expression shows a 5.0-kb dNOS transcript present in heads.
Each lane contained 10 ,ug of poly(A)+ mRNA isolated from Drosophila heads (H) or bodies (B). The Northern blot was hybridized with the dNOS
cDNA. Positions of size markers (in kb) are shown on the left. The blot was overprobed with a myosin light chain (MLC) probe (47) to normalize
for RNA concentration. (B) The dNOS gene expresses two alternatively spliced mRNA species. RT-PCR reactions were performed on poly(A)+
mRNA isolated from Drosophila heads, and the products were resolved on an 8% polyacrylamide gel. Arrows indicate the positions of DNA
fragments of expected sizes: the 444-bp long-form fragment and the 129-bp short-form fragment (lane, + RNA). Other bands present in this lane
are artifacts from heteroduplexes that failed to denature. Poly(A) + mRNA was omitted from the control reaction (lane, - RNA), which otherwise
was done in identical conditions. Size markers (kb ladder) are shown in the middle lane (KB). (C) Alignment of deduced amino acid sequences
of two protein isoforms of DNOS and mouse nNOS implies conservation of the splicing pattern between these two genes. The upper half of the
figure shows the relation between two conceptual Drosophila NOS proteins, DNOS-1 and DNOS-2, corresponding to the longer and shorter
RT-PCR products, respectively. The lower half of the figure shows the relationship between corresponding regions from two protein isoforms of
the mouse nNOS, n-NOS-1 and n-NOS-2. Numbers indicate positions of amino acid residues relative to the first methionine in the respective ORFs.
Biochemistry: Regulski and Tully
9076 Biochemistry: Regulski and Tully
Our data indicate that DNOS protein is a homolog of
constitutively expressed vertebrate NOS enzymes which are
regulated by transient changes in the concentration of intra-
cellular Ca2+. Further biochemical characterization of the
DNOS protein may reveal closer functional homology to either
the nNOS or the endothelial NOS. Preliminary data also
suggest the presence of other NOS homologs in the Drosophila
genome. Characterization of these candidate genes should
contribute further insights to NOS function in fruit flies and
to the evolution of NOS in vertebrates and invertebrates.
Identification of this well-conserved NOS gene in Drosoph-
ila is yet another example of the universality of molecular
mechanisms involved with signaling and plasticity. Over the
last 20 years, evidence has accumulated to reveal homologous
genes involved in different aspects of neuronal plasticity
between vertebrates and invertebrates. These include devel-
opmental plasticity in adults (60-62), synaptic plasticity (60,
63), and behavioral plasticity (64, 65). Recently, memory
formation in fruit flies has been dissected genetically into
component phases, just as has been done pharmacologically in
vertebrates (66, 67). Molecular genetic experiments then dem-
onstrated that long-term memory formation in Drosophila can
be modulated by manipulating the expression of different
isoforms of a cAMP-response-element-binding protein
(CREB) transcription factor (68, 69). Overexpression of a
repressor isoform disrupts long-term memory, while overex-
pression of the activator isoform enhances long-term memory.
Similarly in mice, disruption of the CREB gene function blocks
long-term memory (70). Thus, we anticipate that study of
genetic disruptions of NOS function in fruit flies will confirm
and extend our understanding of developmental and behav-
ioral plasticity.
We thank Drs. D. Bredt and S. Snyder for the gift of rat nNOS
cDNA, Dr. P. Salvaterra for the Drosophila head cDNA library, Jerry
Yin for advice on RT-PCR experiments, Jonathan Wallach and Jim
DeZazzo for advice on cell culture experiments, Grisha Enikolopov
and Natasha Peunova for helpful discussions, and Carl Nathan for
comments on the manuscript. This work was supported by National
Institutes of Health Postdoctoral Fellowship GM13643 (to M.R.) and
a John Merck Scholarship for the Study of Developmental Disabilities
in Children (to T.T.).
1. Marletta, M. (1994) Cell 78, 927-930.
2. Nathan, C. & Xie, Q.-w. (1994) Cell 78, 915-918.
3. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R. &
Snyder, S. H. (1991) Nature (London) 351, 714-718.
4. Lamas, S., Marsden, P. A., Li, G. K., Tempst, P. & Michel, T. (1992) Proc.
Natl. Acad. Sci. USA 89, 6348-6352.
5. Sessa, W. C., Harrison, J. K., Barber, C. M., Zeng, D., Durieux, M. E.,
D'Angelo, D. D., Lynch, K. R. & Peach, M. J. (1992) J. Biol. Chem. 267,
15274-15276.
6. Xie, Q., Cho, H., Calaycay, J., Mumford, R. A., Swiderek, K., Lee, T. D.,
Ding, A., Troso, T. & Nathan, C. (1992) Science 256, 225-228.
7. Dinerman, J. L., Dawson, T. M., Schell, M. J., Snowman, A. & Snyder, S. H.
(1994) Proc. Natl. Acad. Sci. USA 91, 4214-4218.
8. Schmidt, H. H. & Walter, U. (1994) Cell 78, 919-925.
9. Bredt, D. S. & Snyder, S. H. (1994) Neuron 13, 301-313.
10. Peunova, N. & Enikolopov, G. (1995) Nature (London) 375, 68-73.
11. Bohme, G. A., Bon, C., Stutzman, J.-M., Doble, A. & Blanchard, J.-C.
(1991) Eur. J. Pharmacol. 199, 379-381.
12. Haley, J. E., Wilcox, G. L. & Chapman, P. F. (1992) Neuron 8, 211-216.
13. O'Dell, T. J., Hawkins, R. D., Kandel, E. R. & Arancio, 0. (1991) Proc.
Natl. Acad. Sci. USA 88, 11285-11289.
14. Schuman, E. M. & Madison, D. V. (1991) Science 254, 1503-1506.
15. Shibuki, K. & Okada, D. (1991) Nature (London) 349, 326-328.
16. Chapman, P. F., Atkins, C. M., Allen, M. T., Haley, J. E. & Steinmetz, J. E.
(1992) NeuroReport 3, 567-570.
17. Bohme, G. A., Bon, C., Lemaire, M., Reibaud, M., Piot, O., Stutzman,
J.-M., A., D. & Blanchard, J.-C. (1993) Proc. Natl. Acad. Sci. USA 90,
9191-9194.
18. Holscher, C. & Rose, S. P. R. (1992) Neurosci. Lett. 145, 165-167.
19. Rickard, N. S., Ng, K. T. & Gibbs, M. E. (1994) Behav. Neurosci. 108,
640-644.
20. Bannerman, D. M., Chapman, P. F., Kelly, P. A. T., Butcher, S. P. &
Morris, R. G. M. (1994) J. Neurosci. 14, 7404-7414.
21. Bannerman, D. M., Chapman, P. F., Kelly, P. A. T., Butcher, S. P. &
Morris, R. G. M. (1994) J. Neurosci. 14, 7415-7425.
22. Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H. & Fishman, M. C.
(1993) Cell 75, 1273-1286.
23. O'Dell, T. J., Huang, P. L., Dawson, T. M., Dinerman, J. L., Snyder, S. H.,
Kandel, E. R. & Fishman, M. C. (1994) Science 265, 542-546.
24. McGinnis, W. M., Levine, M. S., Hafen, E., Kuroiwa, A. & Gehring, W. J.
(1984) Nature (London) 308, 428-433.
25. Sambrook, J., Fritsch, E. F. & Maniatis, T., eds. (1989) Molecular Cloning:
A Laboratory Manual (Cold Spring Harbor Lab. Press, Plainview, NY), 2nd
Ed.
26. Tanaka, M. & Herr, W. (1990) Cell 60, 375-386.
27. Imperiale, M. J., Feldman, L. T. & Nevins, J. R. (1983) Cell 35, 127-136.
28. Bredt, D. S. & Snyder, S. H. (1990) Proc. Natl. Acad. Sci. USA 87, 682-685.
29. Guan, K. & Dixon, J. E. (1991) Anal. Biochem. 192, 262-267.
30. Hannon, G. J., Demetrick, D. & Beach, D. (1993) Genes Dev. 7,2378-2391.
31. Chomczynski, P. & Sacchi, N. (1987) Anal. Biochem. 162, 156-159.
32. Cavener, D. R. (1987) Nucleic Acids Res 15, 1353-1361.
33. Xie, Q.-w., Cho, H., Kashiwabara, Y., Baum, M., Weidner, J. R., Elliston,
K., Mumford, R. & Nathan, C. (1994). J. Biol. Chem. 269, 28500-28505.
34. Karplus, P. A., Daniels, M. J. & Herriott, J. R. (1991) Science 251, 60-66.
35. McMillan, K., Bredt, D. S., Hirsch, D. J., Snyder, S. H., Clark, J. E. &
Masters, B. S. S. (1992) Proc. Natl. Acad. Sci. USA 89, 11141-11145.
36. Renaud, J.-P., Boucher, J.-L., Vandon, S., Delaforge, M. & Mansuy, D.
(1993) Biochem. Biophys. Res. Commun. 192, 53-60.
37. Richards, M. K. & Marletta, M. A. (1994) Biochemistry 33, 14723-14732.
38. O'Neil, K. T. & DeGrado, W. F. (1990) Trends Biochem. Sci. 15, 59-64.
39. Klatt, P., Schmid, M., Leopold, E., Schmidt, K., Werner, E. R. & Mayer,
B. (1994) J. Biol. Chem. 269, 13861-13866.
40. Ghosh, D. K. & Stuehr, D. J. (1995) Biochemistry 34, 801-807.
41. Pearson, R. B. & Kemp, B. E. (1991) Methods Enzymol. 200, 62-81.
42. Gerber, H.-P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S.
& Schaffner, W. (1994) Science 263, 808-811.
43. Franks, R. G. & Crews, S. T. (1994) Mech. Dev. 45, 269-277.
44. Geller, D. A., Lowenstein, C. J., Shapiro, R. A., Nussler, A. K., DiSilvio,
M., Wang, S. C., Nakayama, D. K., Simmons, R. L., Snyder, S. H. & Billiar,
T. R. (1993) Proc. Natl. Acad. Sci. USA 90, 3491-3495.
45. Iyengar, R., Steuhr, D. J. & Marletta, M. A. (1987) Proc. Natl. Acad. Sci.
USA 84, 6369-6373.
46. Rees, D. D., Palmer, R. M. J., Schulz, R., Hodson, H. F. & Moncada, S.
(1990) Br. J. Pharmacol. 101, 746-752.
47. Parker, V. P., Falkenthal, S. & Davidson, N. (1985) Mol. Cell. Biol. 5,3058.
48. Ogura, T., Yokoyama, T., Fujisawa, H., Kurashima, Y. & Esumi, H. (1993)
Biochem. Biophys. Res. Commun. 193, 1014-1022.
49. Radomski, M. W., Martin, J. F. & Moncada, S. (1992) Philos. Trans. R. Soc.
London B 334, 129-133.
50. Elphick, M. R., Green, I. C. & O'Shea, M. (1993) Brain Res. 619, 344-346.
51. Ribeiro, J. M. C. & Nussenzweig, R. H. (1993) FEBS Lett. 330, 165-168.
52. Elofsson, R., Carlberg, M., Moroz, L., Nezlin, L. & Sakharov, D. (1993)
NeuroReport 4, 279-282.
53. Muller, U. (1994) Eur. J. Neurosci. 6, 1362-1370.
54. Gelperin, A. (1994) Nature (London) 369, 61-63.
55. Hope, B. T., Michael, G. J., Knigge, K. M. & Vincent, S. R. (1991) Proc.
Natl. Acad. Sci. USA 88, 2811-2814.
56. Dawson, T. M., Bredt, D. S., Fotuhi, M., Hwang, P. M. & Snyder, S. H.
(1991) Proc. Natl. Acad. Sci. USA 88, 7797-7801.
57. Ogura, T., Fujisawa, H., Yokoyama, T., Kurashima, Y. & Esumi, H. (1994)
Proceedings ofthe Third International Meeting on Biology ofNitric Oxide, ed.
Moncada, S. (Portland Press, London).
58. Baek, K. J., Thiel, B. A., Lucas, S. & Stuehr, D. J. (1993) J. Biol. Chem. 268,
21120-21129.
59. Nathan, C. & Xie, Q.-w. (1994) J. Biol. Chem. 269, 13725-13728.
60. Zhong, Y. & Wu, C.-F. (1991) Science 251, 198-201.
61. Heisenberg, M., Heusipp, M. & Wanke, C. (1995) J. Neurosci. 15, 1951-
1960.
62. Pyza, E. & Meinertzhagen, I. A. (1995) J. Neurosci. 15, 407-418.
63. Alberini, C. M., Ghirardi, M., Metz, R. & Kandel, E. R. (1994) Cell 76,
1099-1114.
64. Tully, T. (1991) in Neurobiology of Learning, Emotion and Affect, ed.
Madden, J. (Raven, New York), pp. 30-66.
65. Wolf, R. & Heisenberg, M. (1991) J. Comp. Physiol. A 169, 699-705.
66. DeZazzo, J. & Tully, T. (1995) Trends Neurosci. 18, 212-217.
67. Tully, T., Preat, T., Boynton, S. C. & Del Vecchio, M. (1994) Cell 79,35-47.
68. Yin, J. C. P., Wallach, J. S., Vecchio, M. D., Wilder, E. L., Zhou, H., Quinn,
W. G. & Tully, T. (1994) Cell 79, 49-58.
69. Yin, J. C. P., Vecchio, M. D., Zhou, H. & Tully, T. (1995) Cell 81, 107-115.
70. Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G. & Silva,
A. J. (1994) Cell 79, 59-68.
Proc. Natl. Acad. Sci. USA 92 (1995)
